01/12/2022
Davidson, P., & Amir, L. (Series Eds.) (2020-22). Covid-19-related assessments for Grade 12 Biology. Retrieved Month Date, Year, from
Part 2: Student publications (2022)
Deep Learning
Chan, S. Y. (2022). The structure of SARS-CoV-2 Omicron variant in enabling host cell entry. URL: https://bit.ly/3aQSc1u
Chan, S. Y. (2022). Understanding how mRNA vaccines work. URL: https://bit.ly/3He4m0K
Ramiza, A. (2022). Structure of spike protein and mutations occurring in the Delta variant. URL: https://bit.ly/3zsZuTH
Ramiza, A. (2022). Potential of CRISPR Cas12 and Cas13 in diagnosing COVID-19. URL: https://bit.ly/3NLqVw4
Toh, J. L. M. (2022). The hypothetical emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) based on genomic and protein sequence. URL: https://bit.ly/3HgOo6c
Wong, Y. K. (2022). Covid-19 virus replication in a host cell. URL: https://bit.ly/3MIWA02
Hyun, S. (2022). Nanolipid structure of mRNA vaccine. URL: https://bit.ly/39kdLaH
Hyun, S. (2022). Mutations of SARS-CoV-2. URL: https://bit.ly/3HfC7i4
Tan, A. H. T. (2022). A structural comparison of omicron and delta Covid-19 variants of concern. URL: https://bit.ly/3xrYa0x
Teh, A. Z. W. (2022). 4′-fluorouridine antiviral against SARS-CoV-2. URL: https://bit.ly/3n4IjA9
Yong, J. Y. (2022). Omicron and Delta variants of SARS-CoV-2: A comparison of spike protein structure. URL: https://bit.ly/3Os7h8x
Yong, J. Y. (2022). COVID-19 replication in a host cell. URL: https://bit.ly/3b9G2RQ
Wong, Y. S. (2022). A review of the Omicron variant that is highly resistant against antibody-mediated neutralization. URL: https://bit.ly/3bfsPac
Lee, S. (2022). Progress of mRNA-based COVID-19 vaccine developments. URL: https://bit.ly/3HBhsFl
Tong, Z. I. Y .S. (2022). How the structure of Omicron enables host cell entry. URL: https://bit.ly/3Os81dO
Tong, Z. I. Y .S. (2022). Action of Molnupiravir against Covid-19. URL: https://bit.ly/3Oss63K
Mahadzer, M. (2022). Development and investigation of a rapid SARS-CoV-2 antigen detection test for COVID-19 diagnosis. URL: https://bit.ly/3zUTMKw
Tasneem, M. (2022). Mutation-induced structural changes of Delta variant and its implication in functional characteristics of the virus.
URL: https://docs.google.com/document/d/e/2PACX-1vTxnh-YtqhkTYt-GaK8h1AcgWXHzpMht3h7Ogs9nA6XvEXLm_mVdY20p48kF0PXiwQI7RDnkkBnAi7h/pub
Tasneem, M. (2022). Molnupiravir: Potential antiviral oral drug to fight Covid-19.
URL: https://docs.google.com/document/d/e/2PACX-1vTZYIT1DSF42lEmqUweBuXy9gjrdkI9Raac5KuaQw5fnpgS6vBres0cHeb7NAEuehKSfscQeITJBbZQ/pub
Jeem, A. F. (2022). CRISPR in viral inhibition and detection of SARS-CoV-2 and its variants.
URL: https://docs.google.com/document/d/e/2PACX-1vQ2DgtNsqhoKXZLS6KbiZQ8BL_NTZCMOzxG7rOplCXIMv7VH1_CLX_XHApCdNy9JNAi7i9tIk0hvexx/pub
Saini, E. K. (2022). How the structures of SARS-CoV-2 and the delta variant enables host cell entry.
URL: https://docs.google.com/document/d/e/2PACX-1vQhQ2bD7y9iW5wYTMDhpcRkoaJmkP0jSMwiyLonv5rJ7KIWh9i-BIxTUmJ3BfXArmAJFVGMPEKKufHv/pub
Saini, E. K. (2022). CRISPR-Cas13b: Potential therapeutic option for SARS-CoV-2.
URL: https://docs.google.com/document/d/e/2PACX-1vSqpzyiT24_jGc-j5pUphzXHgwIWXg_lgAV3VsE2x1_guE18mktzx-XJmzwZHVtjn4hyTTsPlr9AyBi/pub
Chae, H. (2022). The evolutionary history of SARS-CoV-2.
URL: https://docs.google.com/document/d/e/2PACX-1vTIo0i3HA7vdR-GfOmLezOm8fpOagLRoIPptkokyWQ-KQue4L_HP3iAvLJ5vKgYM8bfyrN_1rbcOtHU/pub
Chae, H. (2022). Delta and Delta Plus structures and their impact on antibodies.
URL: https://docs.google.com/document/d/e/2PACX-1vRy1YDOCAjsFsGaTS_D8-NBMJ1lRF6HoSix_kEY7zgZDZHgvUJqrEDjEslqhP2q2LIKAEnuhJpJwAWj/pub
Shayesteh, R. (2022). A review and comparison of two currently developed vaccines against SARS-CoV-2.
URL: https://docs.google.com/document/d/e/2PACX-1vT8ptfTNF_IsCEtxOK8sflfSiiqz0um9oLEPfPkQYUcHeOVMqGOFs8SCfcVwz_xU5gBibspi8A93Snw/pub
Ho, R. Z. (2022). Structure of the delta variant and Covid-19 host cell entry.
URL: https://docs.google.com/document/d/e/2PACX-1vTzG8DzrM8s9WVRbMO7ZMXr4eCtNsenO_-Fta_PewWtkbP4jjSF3D-nYRgpBX-fHulRcrgv6YB7ogfU/pub
Ho, R. Z. (2022). Molnupiravir’s antiviral properties against Covid-19.
URL: https://docs.google.com/document/d/e/2PACX-1vQcdakhIxXMyld4DFnhfuSDVUPAOLII6NCu7VfsAC69vjh3hMLNrG9FUogPcYFnH4L_TwPxFMxmUCX5/pub
Ramiza, A. (2022). A critique of a study on the effects of COVID-19 on menstruation and s*x hormones. URL: https://bit.ly/3NYMDMM
Toh, J. L. M. (2022). A journal critique of Douaud et al. (2022). URL: https://bit.ly/3xGpppy
Teh, A. Z. W. (2022). A critique on a study about Covid-19 chemosensory dysfunction symptoms in Malaysia. URL: https://bit.ly/3HyG3ut
Lee, S. (2022). A journal critique of Douaud et al. (2022). URL: https://bit.ly/3N5rqQG
Ong, E. (2022). Journal critique on altered smell and taste: Anosmia, parosmia and the impact of long Covid-19. https://bit.ly/3zzgas1
Chae, H. (2022). A journal critique of Liotta et al. (2020).
URL: https://docs.google.com/document/d/e/2PACX-1vSV0oF5kQ2eqx54yZv5kwlZv4l4kDnTfDwTYzTcahtsyrCF_NhtyHNazo1yPG7BEmFCdn_rhQ9jRbls/pub
Shayesteh, R. (2022). A critique of a study on the adverse impacts of COVID-19 on the kidney.
URL: https://docs.google.com/document/d/e/2PACX-1vQxGtgy_Gy7ImR1dOGcSxmqu8RHKlvyAxj_cCMxgzivK6FNOwVq54JM7k2iyvRors9mjVSURUuxk1N-/pub
Ho, R. Z. (2022). Review of neurological complications associated with COVID-19.
URL: https://docs.google.com/document/d/e/2PACX-1vR8a1TN2GKerZKoFrDrWW0eN8RSl2TL_MeoQ8u5IniifzlaUpxJeH_BI-ip4aoOonMQB4qmVFR26Qu0/pub
COVID-19-RELATED ASSESSMENTS FOR GRADE 12 BIOLOGY | *See 'Project Log' tab for articles*. This project showcases online assessments substituting live face-to-face assessments, related to and arising from the Covid19 pandemic movement control order (lockdown) at a Canadian Pre-University programme in...
